| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.1229045 |
| P698 | PubMed publication ID | 23118172 |
| P50 | author | Andrew J. Tatem | Q29397317 |
| Peter W. Gething | Q30508504 | ||
| Justin M Cohen | Q42305831 | ||
| P2093 | author name string | Aaron M Woolsey | |
| Bruno Moonen | |||
| Oliver J Sabot | |||
| P2860 | cites work | A new world malaria map: Plasmodium falciparum endemicity in 2010 | Q17485680 |
| Artemisinin-resistant malaria: research challenges, opportunities, and public health implications | Q21032532 | ||
| Artemisinin Resistance in Plasmodium falciparum Malaria | Q22061852 | ||
| Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests | Q28477670 | ||
| The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets | Q33267919 | ||
| Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review | Q33667689 | ||
| The relationship between reported fever and Plasmodium falciparum infection in African children | Q33843220 | ||
| Population distribution, settlement patterns and accessibility across Africa in 2010. | Q34171312 | ||
| Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. | Q34277322 | ||
| Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change | Q34832467 | ||
| The ACTwatch project: methods to describe anti-malarial markets in seven countries | Q35554925 | ||
| A national policy for malaria elimination in Swaziland: a first for sub-Saharan Africa | Q35560535 | ||
| Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries | Q35582805 | ||
| Standardizing estimates of the Plasmodium falciparum parasite rate | Q36131159 | ||
| Funding for malaria control 2006-2010: a comprehensive global assessment | Q36240069 | ||
| Changes in the burden of malaria in sub-Saharan Africa | Q37773536 | ||
| P433 | issue | 6107 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| public health | Q189603 | ||
| P1104 | number of pages | 3 | |
| P304 | page(s) | 612-614 | |
| P577 | publication date | 2012-11-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Public health. Optimizing investments in malaria treatment and diagnosis | |
| P478 | volume | 338 |
| Q90235722 | "Remarkable solutions to impossible problems": lessons for malaria from the eradication of smallpox |
| Q37089513 | Advances in mapping malaria for elimination: fine resolution modelling of Plasmodium falciparum incidence |
| Q36439747 | Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa |
| Q36111327 | Bioeconomic analysis of child-targeted subsidies for artemisinin combination therapies: a cost-effectiveness analysis |
| Q40207160 | Comparing decisions for malaria testing and presumptive treatment: a net health benefit analysis |
| Q34677891 | Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis |
| Q35115434 | Determinants of malaria diagnostic uptake in the retail sector: qualitative analysis from focus groups in Uganda |
| Q35710906 | Determinants of price setting decisions on anti-malarial drugs at retail shops in Cambodia |
| Q35610012 | Effect of diagnostic testing on medicines used by febrile children less than five years in 12 malaria-endemic African countries: a mixed-methods study |
| Q30855800 | Engaging the private sector in malaria surveillance: a review of strategies and recommendations for elimination settings. |
| Q39393283 | Estimated under-five deaths associated with poor-quality antimalarials in sub-Saharan Africa. |
| Q92580358 | False-negative malaria rapid diagnostic test results and their impact on community-based malaria surveys in sub-Saharan Africa |
| Q37154025 | Global malaria connectivity through air travel |
| Q36295377 | Introducing malaria rapid diagnostic tests in private medicine retail outlets: A systematic literature review |
| Q49451616 | Introducing rapid diagnostic tests for malaria to drug shops in Uganda: a cluster-randomized controlled trial |
| Q40072334 | Modelling the drivers of the spread of Plasmodium falciparumhrp2 gene deletions in sub-Saharan Africa |
| Q36947011 | Over-diagnosis of malaria by microscopy in the Kilombero Valley, Southern Tanzania: an evaluation of the utility and cost-effectiveness of rapid diagnostic tests |
| Q36306811 | Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003-2015: a modelling study using data from national surveys |
| Q37550665 | Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study |
| Q28397448 | Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study |
| Q28537811 | Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies |
| Q35159964 | Price subsidies increase the use of private sector ACTs: evidence from a systematic review |
| Q39163862 | Public health. From financing to fevers: lessons of an antimalarial subsidy program |
| Q56387524 | Rapid diagnostic tests for malaria |
| Q47327249 | The US President's Malaria Initiative, Plasmodium falciparum transmission and mortality: A modelling study. |
| Q28830128 | The impact of pyrethroid resistance on the efficacy and effectiveness of bednets for malaria control in Africa |
| Q52603614 | Understanding Unlicensed Drug Vendor Practices Related to Childhood Malaria in One Rural District of Uganda: An Exploratory Study. |
| Q31157553 | Understanding private sector antimalarial distribution chains: a cross-sectional mixed methods study in six malaria-endemic countries |
| Q33604549 | What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism |
Search more.